MIR4469: A Drug Target / Disease Biomarker (G100616115)
MIR4469: A Drug Target / Disease Biomarker
MIR4469 is a protein that is expressed in various tissues throughout the body. It is a member of the Mir gene family, which encodes for a family of cytoskeleton-associated proteins. MIR4469 is unique among these proteins because it has a unique structure that allows it to interact with various signaling molecules. This interaction with molecules has led to its potential as a drug target or biomarker.
MIR4469 is a 21-kDa protein that is expressed in the brain, heart, and skeletal muscles. It is localized to the endoplasmic reticulum (ER) and can interact with various signaling molecules, including microtubules, actin filaments, and protein-protein interaction (PPI) networks. This interaction with these molecules makes MIR4469 an attractive target for drug development because it can modulate their activity.
One of the ways that MIR4469 can interact with signaling molecules is through its role in the regulation of microtubule dynamics. Microtubules are protein structures that play a central role in the mechanical properties of cells and are involved in various cellular processes, including cell division, intracellular transport, and cell signaling. MIR4469 has been shown to interact with the protein tubulin, which is a key component of microtubules. This interaction with tubulin has been shown to alter microtubule stability and dynamics, which can have significant implications for the regulation of cellular processes.
Another way that MIR4469 can interact with signaling molecules is through its role in the regulation of actin filament dynamics. Actin filaments are a type of protein structure that are involved in the regulation of cell signaling and are composed of two filaments that are held together by a protein called actinin. MIR4469 has been shown to interact with the protein F-actinin, which is a key component of actin filaments. This interaction with actinin has been shown to alter actin filament stability and dynamics, which can also have significant implications for the regulation of cellular processes.
MIR4469 can also interact with various signaling molecules through its role in the regulation of protein-protein interaction networks. Protein-protein interaction networks are complex systems of proteins that interact with each other in a variety of ways. MIR4469 has been shown to interact with a variety of proteins, including the protein heat shock protein (Hsp70), which is involved in the regulation of various cellular processes. This interaction with Hsp70 has been shown to alter Hsp70 function and contribute to the regulation of cellular processes.
In addition to its role in the regulation of microtubule and actin filament dynamics, MIR4469 has also been shown to interact with other signaling molecules that are involved in the regulation of cellular processes. For example, MIR4469 has been shown to interact with the protein tyrosine phosphatase (TKP), which is involved in the regulation of cellular signaling processes. This interaction with TKP has been shown to alter TKP function and contribute to the regulation of cellular processes.
MIR4469 is also of interest as a potential biomarker because of its unique structure and the signaling processes that it is involved in. The regulation of microtubule and actin filament dynamics is a critical process that is involved in the regulation of various cellular processes, including cell signaling, intracellular transport, and cell division. MIR4469 is involved in these processes, which makes it an attractive target for the development of drugs that can modulate microtubule and actin filament dynamics. In addition, the regulation of protein-protein interaction networks is also an important process that is involved in the regulation of cellular processes, and MIR4469
Protein Name: MicroRNA 4469
The "MIR4469 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4469 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A
